Patents by Inventor Rob Sellar

Rob Sellar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Inhibition of JAK-STAT signaling inhibits formation of neutrophil extracellular traps (NETs)
    Patent number: 11426405
    Abstract: The methods described herein include methods for the treatment of subjects who have Clonal Hematopoiesis of Indeterminate Potential (CHIP) or a Philadelphia-negative myeloproliferative neoplasm (MPN), e.g., polycythaemia vera (PV) or essential thrombocythaemia (ET), using inhibitors of JAK-STAT signaling.
    Type: Grant
    Filed: December 4, 2018
    Date of Patent: August 30, 2022
    Assignees: The Brigham and Women's Hospital, Inc., Children's Medical Center Corporation
    Inventors: Rob Sellar, Benjamin Ebert, Ofir Wolach, Kimberly Martinod, Denisa Wagner
  • Inhibition of JAK-STAT Signaling Inhibits Formation of Neutrophil Extracellular Traps (NETs)
    Publication number: 20190167680
    Abstract: The methods described herein include methods for the treatment of subjects who have Clonal Hematopoiesis of Indeterminate Potential (CHIP) or a Philadelphia-negative myeloproliferative neoplasm (MPN), e.g., polycythaemia vera (PV) or essential thrombocythaemia (ET), using inhibitors of JAK-STAT signaling.
    Type: Application
    Filed: December 4, 2018
    Publication date: June 6, 2019
    Inventors: Rob Sellar, Benjamin Ebert, Ofir Wolach, Kim Martinod, Denisa Wagner